Cost-effectiveness of Extracorporeal Life Support Treatment
A Multicenter Prospective Observational Cohort Study Determining the Cost-effectiveness of Extracorporal Life Support (ECLS) Treatment
1 other identifier
observational
200
1 country
1
Brief Summary
This study evaluates patients on ECLS treatment as considered appropriate with mortality and health related Quality of life and costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2016
CompletedFirst Posted
Study publicly available on registry
July 19, 2016
CompletedStudy Start
First participant enrolled
December 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedSeptember 25, 2019
September 1, 2019
2.1 years
July 15, 2016
September 24, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
health related quality of life
health related quality of life with EQ-5D questionnaire at 6 and 12 months
12 months
Interventions
Quality of Care
Eligibility Criteria
Critically ill patients on the ICU treated with extracorporeal life support
You may qualify if:
- Admitted to intensive care
- Treated with extracorporeal life support
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center Groningen
Groningen, 9700 RB, Netherlands
Related Publications (2)
Jolink FEJ, Onrust M, Dos Reis Miranda D, Mandigers L, Delnoij T, Maas JJ, Raasveld SJ, Vlaar APJ, Donker DW, Scholten E, de Metz J, van den Brule J, Kuijpers M, Vermeulen KM, van der Voort PHJ, van den Bergh WM, Oude Lansink-Hartgring A; Dutch Extracorporeal Life Support (ECLS) Study Group. Five Years After Extracorporeal Membrane Oxygenation: A Prospective Cohort Study of Health-Related Quality of Life and Patient Outcomes. Crit Care Med. 2025 Dec 1;53(12):e2487-e2496. doi: 10.1097/CCM.0000000000006900. Epub 2025 Oct 15.
PMID: 41091003DERIVEDOude Lansink-Hartgring A, Dos Reis Miranda D, Donker DW, Maas JJ, Delnoij T, Kuijpers M, van den Brule J, Scholten E, Endeman H, Vlaar APJ, van den Bergh WM; Dutch ECLS study group. Cost-effectiveness in extracorporeal life support in critically ill adults in the Netherlands. BMC Health Serv Res. 2018 Mar 9;18(1):172. doi: 10.1186/s12913-018-2964-6.
PMID: 29523153DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
walter m van den Bergh, MD, PhD
department of critical care, UMCG
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- research coordinator
Study Record Dates
First Submitted
July 15, 2016
First Posted
July 19, 2016
Study Start
December 1, 2017
Primary Completion
January 1, 2020
Study Completion
January 1, 2020
Last Updated
September 25, 2019
Record last verified: 2019-09